Agenus, Inc. (AGEN)
2.92
-0.28
(-8.75%)
USD |
NASDAQ |
Mar 05, 16:00
2.97
+0.05
(+1.71%)
Pre-Market: 08:42
Agenus Cash from Investing (TTM) : 0.393M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Cardiff Oncology, Inc. | 1.342M |
| Curis, Inc. | -0.428M |
| LadRx Corp. | 0.00 |
| Plus Therapeutics, Inc. | 0.287M |
| Windtree Therapeutics, Inc. | -5.972M |